These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 30525855)
1. Effect of symbiotic supplementation on fecal calprotectin levels and lactic acid bacteria, Bifidobacteria, Escherichia coli and Salmonella DNA in patients with cervical cancer. De Loera Rodríguez LH; Ortiz GG; Rivero Moragrega P; Velázquez Brizuela IE; Santoscoy Gutiérrez JF; Rincón Sánchez AR; Charles Niño CL; Cruz Serrano JA; Celis de la Rosa AJ; Pacheco Moisés FP; Medrano González MDR Nutr Hosp; 2018 Dec; 35(6):1394-1400. PubMed ID: 30525855 [TBL] [Abstract][Full Text] [Related]
2. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149 [TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. Holscher HD; Czerkies LA; Cekola P; Litov R; Benbow M; Santema S; Alexander DD; Perez V; Sun S; Saavedra JM; Tappenden KA JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):106S-17S. PubMed ID: 22237870 [TBL] [Abstract][Full Text] [Related]
4. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Mohan R; Koebnick C; Schildt J; Mueller M; Radke M; Blaut M Pediatr Res; 2008 Oct; 64(4):418-22. PubMed ID: 18552710 [TBL] [Abstract][Full Text] [Related]
5. Effect of a symbiotic gel (Lactobacillus acidophilus + Bifidobacterium lactis + inulin) on presence and severity of gastrointestinal symptoms in hemodialysis patients. Viramontes-Hörner D; Márquez-Sandoval F; Martín-del-Campo F; Vizmanos-Lamotte B; Sandoval-Rodríguez A; Armendáriz-Borunda J; García-Bejarano H; Renoirte-López K; García-García G J Ren Nutr; 2015 May; 25(3):284-91. PubMed ID: 25455039 [TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Jung M; Jung S; Kim N; Ahn H; Yun H; Kim KN Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057571 [TBL] [Abstract][Full Text] [Related]
7. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection. Ouwehand AC; ten Bruggencate SJ; Schonewille AJ; Alhoniemi E; Forssten SD; Bovee-Oudenhoven IM Br J Nutr; 2014 Feb; 111(3):465-73. PubMed ID: 23930950 [TBL] [Abstract][Full Text] [Related]
8. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Fallahi G; Motamed F; Yousefi A; Shafieyoun A; Najafi M; Khodadad A; Farhmand F; Ahmadvand A; Rezaei N Turk J Pediatr; 2013; 55(5):475-8. PubMed ID: 24382526 [TBL] [Abstract][Full Text] [Related]
9. Postoperative symbiotic in patients with head and neck cancer: a double-blind randomised trial. Lages PC; Generoso SV; Correia MITD Br J Nutr; 2018 Jan; 119(2):190-195. PubMed ID: 29277158 [TBL] [Abstract][Full Text] [Related]
10. Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula. Oswari H; Prayitno L; Dwipoerwantoro PG; Firmansyah A; Makrides M; Lawley B; Kuhn-Sherlock B; Cleghorn G; Tannock GW J Paediatr Child Health; 2013 Dec; 49(12):1032-9. PubMed ID: 23782263 [TBL] [Abstract][Full Text] [Related]
11. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants. Westerbeek EA; Mørch E; Lafeber HN; Fetter WP; Twisk JW; Van Elburg RM Pediatr Res; 2011 Mar; 69(3):255-8. PubMed ID: 21228732 [TBL] [Abstract][Full Text] [Related]
12. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Shadnoush M; Hosseini RS; Khalilnezhad A; Navai L; Goudarzi H; Vaezjalali M Korean J Gastroenterol; 2015 Apr; 65(4):215-21. PubMed ID: 25896155 [TBL] [Abstract][Full Text] [Related]
13. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial. Garcia-Peris P; Velasco C; Hernandez M; Lozano MA; Paron L; de la Cuerda C; Breton I; Camblor M; Guarner F Eur J Clin Nutr; 2016 Feb; 70(2):170-4. PubMed ID: 26603881 [TBL] [Abstract][Full Text] [Related]
14. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446 [TBL] [Abstract][Full Text] [Related]
15. The effects of AG1® supplementation on the gut microbiome of healthy adults: a randomized, double-blind, placebo-controlled clinical trial. La Monica MB; Raub B; Hartshorn S; Gustat AL; Grdic J; Kirby TO; Townsend JR; Sandrock J; Ziegenfuss TN J Int Soc Sports Nutr; 2024 Dec; 21(1):2409682. PubMed ID: 39352252 [TBL] [Abstract][Full Text] [Related]
16. Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas/CF. Van Biervliet S; Hauser B; Verhulst S; Stepman H; Delanghe J; Warzee JP; Pot B; Vandewiele T; Wilschanski M Clin Nutr ESPEN; 2018 Oct; 27():59-65. PubMed ID: 30144894 [TBL] [Abstract][Full Text] [Related]
17. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240 [TBL] [Abstract][Full Text] [Related]
18. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394 [TBL] [Abstract][Full Text] [Related]
19. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals. Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144 [TBL] [Abstract][Full Text] [Related]
20. Effect of supplemental prebiotics, probiotics and bioactive proteins on the microbiome composition and fecal calprotectin in C57BL6/j mice. Li Y; Hintze KJ; Ward RE Biochimie; 2021 Jun; 185():43-52. PubMed ID: 33609630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]